logo

Health Care News

Share

AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab

Sandoz Presents Interim Analysis From COMPACT Study

Beximco Pharma FY Net Sales Up 28.8% To £212.7 Mln

Eco Animal Health Says H1 Trading Results To Be Below Last Year

Sandoz Agrees To Acquire Aspen's Japanese Operations And Associated Assets

Genentech's Risdiplam Meets Primary Endpoint In Pivotal SUNFISH Trial

AstraZeneca Presents Results From Phase III OLYMPUS And ROCKIES Trials

National Vision Holdings Q3 EPS $0.01 Vs $0.06 Last Year

>